| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/15/2006 | US20060127482 Combination of immuno gene therapy & chemotherapy for treatment of cancer & hyperproliferative diseases |
| 06/15/2006 | US20060127413 Recombinant mva strains as potential vaccines against p. falciparum malaria |
| 06/15/2006 | US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b |
| 06/15/2006 | US20060127405 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy |
| 06/15/2006 | US20060127402 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors |
| 06/15/2006 | US20060127400 Activation of regulatory T cells by alpha-melanocyte stimulating hormone |
| 06/15/2006 | US20060127389 Fused protein with the function of both hemolysis and anticoagulation and use of it |
| 06/15/2006 | US20060127365 Method of cell therapy using fused cell hybrids |
| 06/15/2006 | US20060127364 Insect viruses and their uses in protecting plants |
| 06/15/2006 | US20060127361 Compositions and methods for inducing gene expression |
| 06/15/2006 | US20060127360 Multi-antigen vectors of melanoma |
| 06/15/2006 | US20060127359 Methods and compositions for heat activated gene therapy using cytolethal distending toxin |
| 06/15/2006 | US20060127358 Raav expression systems and methods for enhancing transduction of mammalian neural cells |
| 06/15/2006 | CA2600898A1 Novel cancer antigen peptide and the use thereof |
| 06/15/2006 | CA2597614A1 Plant proteins having an abscisic acid binding site and methods of use |
| 06/15/2006 | CA2594151A1 Methods for the production and secretion of modified peptides |
| 06/15/2006 | CA2593036A1 Methods of producing influenza vaccine compositions |
| 06/15/2006 | CA2593034A1 Compositions and methods based upon the kinase haspin |
| 06/15/2006 | CA2592034A1 Antimicrobial peptides, polypeptides comprising same, methods for preparing same, genes coding for said peptides, vectors, transformed organisms and compositions containing same |
| 06/15/2006 | CA2591297A1 Il-7 variants with reduced immunogenicity |
| 06/15/2006 | CA2590196A1 Use of pta peptides for stratification of individuals having cancer |
| 06/15/2006 | CA2590160A1 Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases |
| 06/15/2006 | CA2590076A1 Method for production of plant cell having chromosome loss |
| 06/15/2006 | CA2589937A1 Rhamnose promoter expression system |
| 06/15/2006 | CA2589823A1 Melibiose operon expression system |
| 06/15/2006 | CA2589688A1 Compounds analogous to lipid membranes in archaebacteria and liposomal compositions including said compounds |
| 06/15/2006 | CA2584309A1 Rnai modulation of rsv, piv and other respiratory viruses and uses thereof |
| 06/14/2006 | EP1669759A1 Novel high throughput screening method of drug for physiologically active protein |
| 06/14/2006 | EP1669464A1 Dna detection method using molecular beacon with the use of monomer fluorescence/excimer fluorescence switching of fluorescent molecule |
| 06/14/2006 | EP1669459A1 Method of purifying succinic acid from fermentation liquid |
| 06/14/2006 | EP1669456A2 Expression cassettes for meristem-preferential expression in plants |
| 06/14/2006 | EP1669455A2 Expression cassettes for vascular tissue-preferential expression in plants |
| 06/14/2006 | EP1669454A2 Genomic DNA encoding a polypeptide capable of inducing the production of interferon-gamma |
| 06/14/2006 | EP1669453A1 Novel nerve stem cell marker |
| 06/14/2006 | EP1669452A1 Promoter of synoviolin gene |
| 06/14/2006 | EP1669451A1 Brain tumor marker and method of diagnosing brain tumor |
| 06/14/2006 | EP1669450A1 Staple type oligonucleotide and drug comprising the same |
| 06/14/2006 | EP1669449A1 Treatment solution for preparing sample solution for nucleic acid amplification reaction and method for detecting nucleic acid by using treatment solution |
| 06/14/2006 | EP1669447A1 SNPs IN 5' REGULATORY REGION OF MDR1 GENE |
| 06/14/2006 | EP1669445A1 Novel vector and utilization of the same |
| 06/14/2006 | EP1669444A1 Method of elevating transformation efficiency in plant by adding copper ion |
| 06/14/2006 | EP1669443A1 Plant dwarfing gene |
| 06/14/2006 | EP1669441A1 Method of differentiating mesenchymal stem cell into liver cell and artificial human liver cell |
| 06/14/2006 | EP1669369A2 Nucleic acid sequence encoding the OPCA gene |
| 06/14/2006 | EP1669366A1 Lipids comprising an aminoxy group |
| 06/14/2006 | EP1669089A1 INHIBITION OF NERVE CELL DEATH BY INHIBITING DEGRADATION OF SHC3, ATF6 OR CREBL1 BY HtrA2 AND METHOD OF AMELIORATING NEURODEGENERATIVE DISEASES |
| 06/14/2006 | EP1669088A1 METHOD OF TREATING DIABETES BY INHIBTING DEGRADATION OF AT LEAST ONE OF CREBL1, ATF6 and HNF-4 ALPHA BY HtrA2 |
| 06/14/2006 | EP1668357A2 Materials and methods relating to breast cancer classification |
| 06/14/2006 | EP1668163A2 Method for the diagnosis/prognosis of neuroblastoma |
| 06/14/2006 | EP1668160A2 Methods, compositions, and kits for the concentration and detection of microorganisms |
| 06/14/2006 | EP1668155A2 Methods for detecting, diagnosing and treating hepatocellular carcinomas (hcc) |
| 06/14/2006 | EP1668144A2 Nucleotide sequences promoting the trans-membrane transport of nucleic acids |
| 06/14/2006 | EP1668143A2 Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 06/14/2006 | EP1668142A1 Modified vaccinia virus ankara (mva) mutant and use thereof |
| 06/14/2006 | EP1668141A2 Methods for enhancing stress tolerance in plants and methods thereof |
| 06/14/2006 | EP1668140A2 Regulation of plant biomass and stress tolerance |
| 06/14/2006 | EP1668139A2 Methods and compositions for enhanced plant cell transformation |
| 06/14/2006 | EP1668138A2 Dihydroflavonol-4-reductase |
| 06/14/2006 | EP1668137A2 Enhancing accumulation of heterologous polypeptides in plant seeds through targeted suppression of endogenous storage proteins |
| 06/14/2006 | EP1668136A2 A process for proteolytic cleavage and purification of recombinant proteins produced in plants |
| 06/14/2006 | EP1668135A2 A non-denaturing process to purify recombinant proteins from plants |
| 06/14/2006 | EP1668134A2 Broad host range pbbr1-based plasmid mutant derivatives having altered plasmid copy number |
| 06/14/2006 | EP1668133A1 Coiled-coil fusion proteins comprising cell receptor domains |
| 06/14/2006 | EP1668132A1 Cytokine involved in epithelial-mesenchymal transition |
| 06/14/2006 | EP1668131A1 C1q related protein |
| 06/14/2006 | EP1668130A2 Modulation of eif4e expression |
| 06/14/2006 | EP1668128A1 Treatment of menorrhagia, dysmenorrhoea or endometriosis |
| 06/14/2006 | EP1668127A1 Method for magnetic bead isolation of nucleic acids |
| 06/14/2006 | EP1668126A1 Method for in vitro evolution of polypeptides |
| 06/14/2006 | EP1668125A2 Modified enzymes, methods to produce modified enzymes and uses thereof |
| 06/14/2006 | EP1668123A1 Use of pks 13 protein coding for condensase of mycolic acids of mycobacteria and related strains as an antibody target |
| 06/14/2006 | EP1668120A2 Method for detecting cancer cells and monitoring cancer therapy |
| 06/14/2006 | EP1668116A1 Methods for enhancing embryo viability |
| 06/14/2006 | EP1668114A2 Polypeptide display libraries and methods of making and using thereof |
| 06/14/2006 | EP1668113A2 Laccases, nucleic acids encoding them and methods for making and using them |
| 06/14/2006 | EP1668112A2 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and essays for making and using |
| 06/14/2006 | EP1668111A2 Osteoarthritis biomarkers and uses thereof |
| 06/14/2006 | EP1668067A2 Crosslinking within coordination complexes |
| 06/14/2006 | EP1668029A2 East coast fever vaccine based on ctl-specific schizont antigens |
| 06/14/2006 | EP1668028A1 Antisense compound and method for selectively killing activated t cells |
| 06/14/2006 | EP1668025A2 Seneca valley virus based compositions and methods for treating disease |
| 06/14/2006 | EP1668024A2 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 06/14/2006 | EP1667732A1 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 06/14/2006 | EP1667731A1 Bispecific oligonucleotide for the treatment of cns malignancies |
| 06/14/2006 | EP1667730A2 Compositions and methods for treating inflammatory lung disease |
| 06/14/2006 | EP1667729A2 Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting ap-1 transcription factors |
| 06/14/2006 | EP1667728A1 Intravascular delivery of non-viral nucleic acid |
| 06/14/2006 | EP1667714A2 Consensus/ancestral immunogens |
| 06/14/2006 | EP1667523A2 Dna vaccine compositions and methods of use |
| 06/14/2006 | EP1667522A2 Modified oligonucleotides for telomerase inhibition |
| 06/14/2006 | EP1667516A1 Method of selecting animal models from animals which have been subject to mutagenesis, and the use of myb transcription factors for screening |
| 06/14/2006 | EP1633864A4 High throughput assay of lp-pla2 activity |
| 06/14/2006 | EP1516050A4 Generation of plants with improved pathogen resistance |
| 06/14/2006 | EP1471931A4 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 06/14/2006 | EP1451367A4 Engineering of leader peptides for the secretion of recombinant proteins in bacteria |
| 06/14/2006 | EP1436401A4 Stem-loop vector system |
| 06/14/2006 | EP1432831A4 Human mitochondrial dna polymorphisms, haplogroups, associations with physiological conditions, and genotyping arrays |
| 06/14/2006 | EP1379650B1 Preferred segments of neural thread protein and methods of using the same |
| 06/14/2006 | EP1328627B1 Method for generating a library of oligonucleotides comprising a controlled distribution of mutations |
| 06/14/2006 | EP1320632B1 Method for determining the age of individuals |